Skip to Main Content

Paper Details

Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial.
Clinical Cancer Research
54
2019
Author NameAffiliation
José BaselgaMemorial Sloan Kettering Cancer Center
Christos SotiriouInstitut Jules Bordet, Universite Libre de Bruxelles (ULB)
  • 1 - 2

Datasets

Release 1.2